+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artivion Inc (AORT) - Product Pipeline Analysis, 2023 Update

  • PDF Icon

    Company Profile

  • 56 Pages
  • June 2023
  • GlobalData
  • ID: 5655746
Artivion Inc (Artivion), formerly CryoLife Inc, is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for the treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products includes physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US and Hechinger, Germany. The company distributes its products through a network of the direct sales force in the UK, Austria, France, Germany, Ireland, and Switzerland, and independent distributors in the rest of Europe, the Middle East, and Africa. It commercializes products in more than 85 countries worldwide. Artivion is headquartered in Atlanta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Artivion Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Artivion Inc Company Overview
  • Artivion Inc Company Snapshot
  • Artivion Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Artivion Inc - Pipeline Analysis Overview
  • Business Description
  • Artivion Inc - Key Facts
  • Artivion Inc - Major Products and Services
  • Artivion Inc Pipeline Products by Development Stage
  • Artivion Inc Ongoing Clinical Trials by Trial Status
  • Artivion Inc Pipeline Products Overview
  • Antyllus
  • Antyllus Product Overview
  • Aortiger
  • Aortiger Product Overview
  • Artivion
  • Artivion Product Overview
  • Ascyrus Medical Dissection Stent
  • Ascyrus Medical Dissection Stent Product Overview
  • Ascyrus Medical Dissection Stent Clinical Trial
  • Biodisc Nucleus Pulposus Replacement
  • Biodisc Nucleus Pulposus Replacement Product Overview
  • Bioglue Surgical Adhesive
  • Bioglue Surgical Adhesive Product Overview
  • Bioglue Surgical Adhesive Clinical Trial
  • CryoValve SGAV
  • CryoValve SGAV Product Overview
  • E-liac Stent Graft System
  • E-liac Stent Graft System Product Overview
  • E-liac Stent Graft System Clinical Trial
  • E-nside TAAA Stent Graft
  • E-nside TAAA Stent Graft Product Overview
  • E-nside TAAA Stent Graft Clinical Trial
  • E-nya Thoracic Stent Graft
  • E-nya Thoracic Stent Graft Product Overview
  • E-nya Thoracic Stent Graft Clinical Trial
  • E-Ventus SX
  • E-Ventus SX Product Overview
  • E-Vita Open Neo
  • E-Vita Open Neo Product Overview
  • E-Vita Open Neo Clinical Trial
  • Neo 2.0
  • Neo 2.0 Product Overview
  • On-X Mechanical Aortic Valve - ELIQUIS
  • On-X Mechanical Aortic Valve - ELIQUIS Product Overview
  • On-X Mitral Heart Valve
  • On-X Mitral Heart Valve Product Overview
  • On-X Mitral Valve-Low INR
  • On-X Mitral Valve-Low INR Product Overview
  • Sanevo
  • Sanevo Product Overview
  • Semtis
  • Semtis Product Overview
  • Synergraft Xenograft Heart Valve
  • Synergraft Xenograft Heart Valve Product Overview
  • Synergraft Xenograft Vascular Graft
  • Synergraft Xenograft Vascular Graft Product Overview
  • Artivion Inc - Key Competitors
  • Artivion Inc - Key Employees
  • Artivion Inc - Key Employee Biographies
  • Artivion Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Artivion Inc, Recent Developments
  • Aug 24, 2022: Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
  • Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
  • Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
  • Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
  • Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
  • Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
  • Apr 29, 2021: CryoLife Reports First Quarter 2021 Financial Results
  • Mar 09, 2021: CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference
  • Feb 11, 2021: CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
  • Jan 28, 2021: CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Artivion Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Artivion Inc Pipeline Products by Equipment Type
  • Artivion Inc Pipeline Products by Indication
  • Artivion Inc Ongoing Clinical Trials by Trial Status
  • Artivion Inc, Key Facts
  • Artivion Inc, Major Products and Services
  • Artivion Inc Number of Pipeline Products by Development Stage
  • Artivion Inc Pipeline Products Summary by Development Stage
  • Artivion Inc Ongoing Clinical Trials by Trial Status
  • Artivion Inc Ongoing Clinical Trials Summary
  • Antyllus - Product Status
  • Antyllus - Product Description
  • Aortiger - Product Status
  • Aortiger - Product Description
  • Artivion - Product Status
  • Artivion - Product Description
  • Ascyrus Medical Dissection Stent - Product Status
  • Ascyrus Medical Dissection Stent - Product Description
  • Ascyrus Medical Dissection Stent - A Prospective, Single Arm, Multi-center Clinical Investigation to Evaluate the Safety and Effectiveness of AMDS in the Treatment of Acute DeBakey Type I Dissection: PERSEVERE
  • Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study
  • Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility, Safety and Performance Trial
  • Ascyrus Medical Dissection Stent - Dissected Aorta Repair through Stent Implantation (DARTS): A Post-market Registry
  • Biodisc Nucleus Pulposus Replacement - Product Status
  • Biodisc Nucleus Pulposus Replacement - Product Description
  • Bioglue Surgical Adhesive - Product Status
  • Bioglue Surgical Adhesive - Product Description
  • Bioglue Surgical Adhesive - A Prospective, Multicenter Study of BioGlue in the Treatment of Chinese Patients with Acute Type A Aortic Dissections
  • Bioglue Surgical Adhesive - Multi-center, Randomized, Controlled Clinical Trial of BioGlue Surgical Adhesive as an Adjunct for Structural Repair and Hemostasis in Chinese Patients with Acute Type A Aortic Dissections
  • CryoValve SGAV - Product Status
  • CryoValve SGAV - Product Description
  • E-liac Stent Graft System - Product Status
  • E-liac Stent Graft System - Product Description
  • E-liac Stent Graft System - Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms
  • E-liac Stent Graft System - Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm with the Branched E-liac Stent Graft
  • E-nside TAAA Stent Graft - Product Status
  • E-nside TAAA Stent Graft - Product Description
  • E-nside TAAA Stent Graft - INNER-B - A Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
  • E-nya Thoracic Stent Graft - Product Status
  • E-nya Thoracic Stent Graft - Product Description
  • E-nya Thoracic Stent Graft - CONFORM-TAA - A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System
  • E-nya Thoracic Stent Graft - CONFORM-TAD- A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System
  • E-Ventus SX - Product Status
  • E-Ventus SX - Product Description
  • E-Vita Open Neo - Product Status
  • E-Vita Open Neo - Product Description
  • E-Vita Open Neo - A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS
  • E-Vita Open Neo - NEO - E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections
  • E-Vita Open Neo - NEOS-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO
  • Neo 2.0 - Product Status
  • Neo 2.0 - Product Description
  • On-X Mechanical Aortic Valve - ELIQUIS - Product Status
  • On-X Mechanical Aortic Valve - ELIQUIS - Product Description
  • On-X Mitral Heart Valve - Product Status
  • On-X Mitral Heart Valve - Product Description
  • On-X Mitral Valve-Low INR - Product Status
  • On-X Mitral Valve-Low INR - Product Description
  • Sanevo - Product Status
  • Sanevo - Product Description
  • Semtis - Product Status
  • Semtis - Product Description
  • Synergraft Xenograft Heart Valve - Product Status
  • Synergraft Xenograft Heart Valve - Product Description
  • Synergraft Xenograft Vascular Graft - Product Status
  • Synergraft Xenograft Vascular Graft - Product Description
  • Artivion Inc, Key Employees
  • Artivion Inc, Key Employee Biographies
  • Artivion Inc, Subsidiaries
  • Glossary
List of Figures
  • Artivion Inc Pipeline Products by Equipment Type
  • Artivion Inc Pipeline Products by Development Stage
  • Artivion Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Edwards Lifesciences Corp
  • Ethicon US LLC
  • CR Bard Inc
  • Medtronic Plc
  • Pfizer Inc
  • Abbott Laboratories
  • MAQUET, Inc.
  • W. L. Gore & Associates Inc
  • Advanced Medical Solutions Group Plc